Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezuclastinib + Sunitinib in GIST
NCT06208748Phase 2Active, not recruiting
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Aug 2024
- Primary completion
- Jun 2026
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bezuclastinib in gastrointestinal stromal tumor (GIST), sponsored by Sarcoma Alliance for Research through Collaboration. Started Aug 2024; status: active, not recruiting.
02
Drugs
bezuclastinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT06208748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208748.